Objectives: Autophagy constitutes a defense mechanism to overcome aging and apoptosis in osteoarthritic cartilage. Several cytokines and transcription factors are linked to autophagy and play an important role in the degradative cascade in osteoarthritis (OA). Cell therapy such as platelet rich plasma (PRP) has recently emerged as a promising therapeutic tool for many diseases including OA. However, its mechanism of action on improving cartilage repair remains to be determined. The purpose of this study is to investigate the effect of PRP on osteoarthritic chondrocytes and to elucidate the mechanism by which PRP contributes to cartilage regeneration. Methods: Osteoarthritic chondrocytes were co-cultured with an increasing concentration of PRP obtained from healthy donors. The effect of PRP on the proliferation of chondrocytes was performed using cell counting and WST8 proliferation assays. Autophagy, apoptosis and intracellular level of IL-4, IL-10, and IL-13 were determined using flow cytometry analyses. Autophagy markers BECLIN and LC3II were also determined using quantitative polymerase chain reaction (qPCR). qPCR and ELISA were used to measure the expression of ADAMDTS-5, MMP3, MMP13, TIMP-1-2-3, aggregan, Collagen type 2, TGF-β, Cox-2, Il-6, FOXO1, FOXO3, and HIF-1 in tissues and co-cultured media. Results: PRP increased significantly the proliferation of chondrocytes, decreased apoptosis and increased autophagy and its markers along with its regulators FOXO1, FOXO3 and HIF-1 in osteoarthritic chondrocytes. Furthermore, PRP caused a dose-dependent significant decrease in MMP3, MMP13, and ADAMTS-5, IL-6 and COX-2 while increasing TGF-β, aggregan, and collagen type 2, TIMPs and intracellular IL-4, IL-10, IL-13. Conclusion: These results suggest that PRP could be a potential therapeutic tool for the treatment of OA.
Platelet rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-inflammatory markers, and decreasing apoptosis in human osteoarthritic cartilage 
Introduction
Osteoarthritis (OA) is a chronic debilitating disease which mainly affects the diarthrodial joints. The pathophysiology of OA involves a cross talk between cartilage, bone and synovial tissue leading to the vicious circle of inflammation and cartilage degradation [1, 2] . Preserving the integrity of cartilage involves maintaining healthy chondrocytes. Autophagy regulates the chondrocyte lifecycle and it constitutes a defense mechanism used by articular cartilage to overcome aging and apoptosis in OA cartilage [3, 4] .
The interplay between catabolic factors and anabolic factors describes the events occurring in osteoarthritic cartilage with a shift towards catabolic mediators. Several anabolic factors such as TGF-β1 and anti-inflammatory cytokines (interleukins IL-4, IL-10 and IL-13) are secreted by chondrocytes, which stimulate the synthesis of extracellular matrix, therefore cartilage repair [5, 6] . Yet, the secretion of these factors is not enough to counterbalance the effect of inflammatory mediators. IL-1β and TNF-α, two major pro-inflammatory cytokines, play the role of stimulators of the inflammatory and degradative cascades in OA [7] . They reduce the transcription factors FOXO protein expression, habitually expressed in normal human cartilage and linked to autophagy [8] . They increase the expression of proteinases MMPs and ADAMTS such as MMP-3/MMP-13/ADAMTS5 inhibit the synthesis of natural protease inhibitors (TIMPs), and increase the synthesis and release of eicosanoids (E2 prostaglandins) to further degrade the joint tissues [9] [10] [11] [12] [13] [14] .
Most of the treatments for OA are palliative and do not stop the progression of the disease nor replace the degrading cartilage. Cell therapy such as platelet rich plasma has recently emerged as a promising therapeutic tool for many diseases including Osteoarthritis.
Platelet rich plasma (PRP) consists of a high concentration of autologous platelets [15] . Dense granules in platelets store and release more than 300 molecules after activation by exposure to collagen or calcium/thrombin [16] . The potential therapeutic effect of PRP is due to various cytokines, growth factors such as platelet derived growth factors (PDGF), transforming growth factors β1 (TGFβ1), insulin like growth factors (IGF), platelet factor 4 (PF-4), fibroblast growth factor 2 (FGF-2) and vascular endothelial growth factor (VEGF) which are thought to accelerate natural healing process and promote cartilage repair [17] [18] [19] . Those cytokines and growth factors recruit resident stem cells to the site of injury, where they are stimulated to secrete additional growth factors and anti-inflammatory cytokines, causing more increase in collagen and matrix synthesis. Furthermore the recruited stem cells will react with the environment to differentiate into cartilage and replace the injured one [20, 21] .
Although numerous clinical trials indicate that PRP is a promising treatment for cartilage injuries and joint inflammation in OA, its mechanism of action on improving cartilage repair remains to be determined. The purpose of this study is to investigate the effect of PRP on osteoarthritic chondrocytes including autophagy and apoptosis, and to elucidate the mechanism by which PRP contributes to cartilage repair and regeneration.
Materials and methods

Chondrocyte Isolation and Culture
Osteoarthritic knee cartilage was obtained from 12 patients undergoing total knee replacement surgery who were diagnosed based on the criteria developed by the American College of Rheumatology Diagnostic Subcommittee for OA/RA (mean age 55 ± 15 years; 8 women and 4 men) and the diagnosis of Kellgren-Lawrence grade 4 osteoarthritis of the knee joint [22] . Saint Joseph University and Hotel Dieu de France (Beirut, Lebanon) Ethics Review Board approved the use of specimens obtained surgically. OA patients were asked to read the consent forms and approve/sign them prior to surgery. Cartilage slices were cut into pieces (2-3 mm 2 ), washed with DMEM (Whittaker MAB Bioproducts, Walkerville, MD), and treated for 15 min with trypsin (10% vol/vol) in a 37°C water bath. The tissues were transferred to DMEM, 5% FBS(Fetal Bovine Serum), penicillinstreptomycin-fungizone, and 2 mg/ml clostridial collagenase type IV (Sigma, St. Louis, MO) and digested overnight on a gyratory shaker. Then, the cells were washed three times with Hank's buffer and cultured in DMEM F12 supplemented with 10% FBS with a cell density 10 6 cells per flask 75 cm 2 . For all experiments, cells were used in primary or first passage culture.
PRP preparation
In order to prepare 6 different samples of PRP, venous blood was collected from 6 healthy donors (mean age 20 ± 15 years) using a sterile 20 ml syringe containing 3.8% sodium citrate solution. Under a laminar flow hood, the blood from the syringe was transferred gently to a 50 ml centrifuge tube. The PRP preparation procedure consisted of two centrifugation steps. The initial centrifugation at 1500 rpm for 15 min at room temperature separates the whole blood into three layers: an upper layer containing mostly platelets and WBC (White Blood Cells), an intermediate thin layer known as the buffy coat rich in WBC, and a bottom layer that consists mostly of RBCs (Red Blood Cells). Most of the red blood cells were eliminated and the upper layer and buffy coat are transferred to an empty sterile tube and centrifuged at 2800 rpm for 8 min for PRP collection.
Cells treatment and morphological observation
To determine the effect of PRP on osteoarthritic chondrocytes a coculture system was created. Osteoarthritic chondrocytes cells were plated in 6-well plates with 1 ml of DMEM: F12, and 10%FBS at a concentration of 10 5 cells/ml. After 48 h, the media was discarded and cells were treated with free serum DMEM or free serum DMEM supplemented with increasing concentration of PRP (5%, 10% and 20%) for another 48 h. Morphological observations were performed under phase-contrast microscope.
Giemsa staining
Cells were seeded on cover slips at density 5×10 3 per slide suspended in 50 µl of serum free media with or without PRP and incubated for 48 h at 37°C. The cells were then washed with phosphate-buffered saline (PBS), and fixed with 1:2 methanol/PBS for 5 min then with methanol 100% for 15 min at room temperature. Cells were immersed in a Giemsa solution for 5 min at room temperature. Staining was followed by rinsing the coverslips for 5 min in water, air-dried, and observing the slides under microscope.
Autophagy detection
We first used propidium iodide staining to detect autophagy. After 48 h of PRP treatment, chondrocytes were harvested and washed by cold phosphate-buffered saline and fixed by cold ethanol. Cells were suspended in 0.3 ml of propidium iodide solution (69 µM propidium iodide (Sigma catalog #P4170) in 38 mM sodium Citrate), then incubated with 10 µl of RNAse (Invitrogen catalog #12091-039) at 37°C for 30-45 min. The fluorescence was read on a Macsquant analyzer device. Next, we used the autophagy assay kit (sigma Aldrich #MAK 138) to determine the formation of autophagosomes by flow cytometry analysis. Last, we used Real-time PCR to detect the autophagy marker BECLIN and the autophagy initiation maker LC3II. Real-time PCR was performed as described below and primers are indicated in the Table 1 .
Proliferation test
The effect of PRP on the proliferation of osteoarthritic chondrocytes was evaluated using a cell -counting kit 8 (CCK-8, sigma Aldrich) according to the manufacturer recommendations. Chondrocytes were treated with different concentration of PRP (5%, 10% and 20%) in 96 well plates. Cells cultured in serum free media without PRP were considered as control. At the indicated time points, the proliferation was evaluated by recording the absorbance at 450 nm of reduced WST-8 (2-(2-methoxy-4-nitrophenyl)−3-(4-nitrophenyl)−5-(2, 4-disulfophenyl)−2-H-tetrazolium, monosodium salt) in triplicate wells per condition.
Apoptosis
To determine the effect of PRP on the apoptosis of osteoarthritic chondrocytes, an annexin V/FITC kit (Miltenyi Biotec) was used according to the manufacturer's instructions. 
Examination of apoptosis by 4,6-diamidino-2-phenylindole, dihydrochloride (DAPI) staining
Osteoarthritic chondrocytes were cultured on glass slides for 48 h then treated by different concentrations of PRP, while the control chondrocytes were cultured in serum free media without PRP. After a 48-h incubation, the slides were rinsed with PBS and fixed in 3.7% formaldehyde for 10 min at room temperature. Following two washes with PBS, cells were stained with 1x DAPI staining diluted in PBS for 15 min. The slides were then visualized on a fluorescence microscope.
Measure of IL-10/IL-4/IL-13 intracellular interleukins
To determine the intracellular expression of IL-10/ IL-4/ IL-13 by the osteoarthritic chondrocytes and to detect the effect of PRP on the expression of IL-10/ IL-4/ IL-13, cells were washed twice with PBS, then fixed and permeabilized using the Cytofix/Cytoperm™ Kit (BD, USA) according to the manufacturer's instructions. Briefly, cells were incubated with a fixation permeabilization solution for 20 min at 4°C. After incubation, cells were washed twice with Perm/Wash™ buffer, and then stained with the appropriate PE-conjugated monoclonal antibodies against human IL-10/ IL-4/ IL-13 (Milteny Biotec) for 30 min at 4°C in the dark. Finally, the cells were washed twice with Perm/Wash™ buffer and re-suspended in ranging buffer for the flow cytometry analysis.
Human protease (MMPs-ADAMTS-5)/protease inhibitor (TIMPs) levels
To test the level of MMP-3, MMP13, ADAMTS5 and TIMP1-2-3 in treated and control cells supernatants, quantitative enzyme linked immunosorbent assays (R & D, Abingdon,-United Kingdom) were performed according to the manufacturer's protocol. The optical density is determined using an ELISA plate reader at 450 nm.
RNA extraction and Real-time PCR
Total RNA from samples were extracted using QIAamp RNA extraction Kit (Qiagen Inc., Valencia, CA, USA). RNA quality and yields were analyzed using nanodrop. Complementary DNA (cDNA) was synthesized from 500 ng of total RNA in a 20 µl reaction solution using iScript™ Cdna-synthesis Kit (Bio-Rad Laboratories, CA).
Real-time PCR was performed with the iQ™ SYBR ® Green Supermix (Bio-Rad Laboratories, CA) in triplicate. The reaction conditions were: Polymerase Activation at 95°C for 5 min, 40 cycles of denaturation at, 95°C for 20 s and annealing and extension at 62°C for 20 s. The relative quantification of gene expression was normalized to the expression of endogenous GAPDH.
Statistical analysis
The experimental data was expressed as mean ± standard deviation. The differences between the groups were analyzed by ANOVA for multiple comparisons followed by appropriate sub-tests when statistical difference was reached. A p < 0.005 value was considered as statistically significant.
Results
Effect of PRP on osteoarthritic chondrocytes proliferation
In order to study the effect of PRP on chondrocytes proliferation, chondrocytes were isolated and treated for 48 h with different concentrations of PRP (5%, 10% and 20%). The microscopic observation showed that the chondrocytes kept their normal morphology following PRP treatments, and showed a dose dependent increase in number, indicating an increase in chondrocyte proliferation (Fig. 1A) . We found a dose-dependent induction of the proliferation of chondrocytes in response to increasing doses of PRP and a significant enhancement with 10% and 20% concentrations. This result was similar for both tests, trypan blue cell count (Fig. 1B) and WST-8 test (Fig. 1C ) (P≤0.005). ADAMTS5  5′-GTCCAAATGCACTTCAGCCA−3′  5′-GGTGGCATCGTAGGTCTGTC−3′  COX2  5′-TGACCAGAGCAGGCAGATGAA−3′  5′-CCACAGCATCGATGTCACCATAG−3′  IL6  5′ -GGTACATCCTCGACGGCATCT−3′  5′ -GTGCCTCTTTGCTGCTTTCAC−3′  Col 2A1  5′-TGCCGGATCTGTGTCTGTGA−3′  5′-GGCAGCAAAGTTTCCACCAA−3′  Aggrecan  5′-AGGCAGCGTGATCCTTACC−3′  5′-GGCCTCTCCAGTCTCATTCTC−3′  TIMP 1  5′-GACCAAGATGTATAAAGGGTTCCAA−3′  5′-GAAGTATCCGCAGACACTCTCCAT−3′  TIMP 2  5′-AGGCGTTTTGCAATGCAGAT−3′  5′-TCCAGAGTCCACTTCCTTCTCACT−3′  TIMP3  5′-CAGGACGCCTTCTGCAACTC−3′  5′-AGCTTCTTCCCCACCACCTT−3′  MMP3  5′-TCGTTGCTGCTCATGAAATTG−3′  5′-GCTTCAGTGTTGGCTGAGTGAA−3′  MMP13 5′-CCGAGGAGAAACAATGATCT−3′ 5′-GCCTGTATCCTCAAAGTGAA−3′ TGFβ Significantly different groups *P < 0.05, **P < 0.005, ***P < 0.001.
PRP enhanced chondrocytes autophagy
In order to investigate if PRP modulate autophagy in osteoarthritic chondrocyte, Giemsa staining was performed. The light microscopic observation of the cells revealed the formation of vacuoles in the cytoplasm. It showed a dose-dependent increase in vacuoles formation with increasing PRP concentration. This suggests the induction of autophagy in OA chondrocytes by PRP (Fig. 2A) . The flow cytometry analysis performed following treatments with autophagosome detection reactifs (autophagy assay kit sigma Aldrich) also demonstrated an increase in autophagosome formation in response to increasing PRP doses (Fig. 2B) . Next, we determined the expression of autophagy markers, BECLIN and LC3II, by real-time PCR in response to PRP. Fig. 2C and D show the data for BECLIN and LC3II expression respectively. Moreover, in order to elucidate if PRP affects the regulators of aging involved in cartilage a qPCR analysis for the expression of FOXO1 and FOXO3 and HIF-1 was performed. Our results showed an upregulation in FOXO1/FOXO3 and HIF-1 mRNA expression respectively with all PRP concentration (P≤0.005) (Fig. 2E-F) .
PRP induces chondrocytes quiescence
Since PRP increased autophagy and autophagy is known to maintain quiescence and reverse senescence, we studied the effect of PRP on chondrocytes quiescence. Chondrocytes were cultured with increasing concentrations of PRP and a flow cytometry analysis was assessed using propidium iodide. Ours results showed that the percentage of quiescent cells which increased from control values of 13.5% to values equal to 25,4%, 60,2%, 92% in response to 5%, 10% and 20% PRP concentration respectively (P≤0.001) (Fig. 3) .
PRP inhibited chondrocytes apoptosis
Since autophagy and apoptosis are inter-related, we wanted to determine if PRP had also an effect on chondrocytes apoptosis. Chondrocytes were harvested after 48 h of culture in presence of increasing concentrations of PRP to perform apoptotic cell death analysis by flow cytometry. Our results showed that 5%, 10% and 20% PRP significantly decreased the apoptotic ratios of osteoarthritic chondrocytes by 37.63%, 37.97% and 38.65% respectively compared to the control (Fig. 4A) (P≤0.001) .
Consistent with these results a DAPI blue fluorescence staining 
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revealed a reduction of chondrocytes apoptosis with all PRP concentration with highest cell reduction seen at 20% PRP. (Fig. 4B) . Furthermore, to examine if PRP induces an alteration in the expression of apoptosis-related genes, we studied the expression of BAD, Caspase-3 and BCL-2 by real time PCR. We observed that PRP significantly decreased the mRNA level of BAD and Caspase-3 and increased the mRNA level of BCL-2 (P≤0.05) (Fig. 4C) .
Effect of PRP on inflammatory mediators
Upregulation of inflammatory mediators in the early and late stages of OA is linked to caspases and inflammasome-dependent responses contributing to the structural changes observed in OA joints. In osteoarthritis, the increase of IL-6 and COX-2 levels and the decrease of TGF-β and intracellular interleukin, IL-4, IL-10 and IL-13, levels expose the cartilage to chronic inflammatory conditions. Hence, we determined the effect of PRP on the above mentioned cytokines levels. we compared TGF-β, IL-6 and COX-2 mRNA levels between control The results were displayed as percentage of controls. Data is representative of five independent experiments as mean ± SD. Significantly different groups *P < 0.05, **P < 0.005, ***P < 0.001.
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and treated chondrocytes. Interestingly, a q-PCR analysis showed a decrease in COX-2 and IL-6 expression in a dose dependent manner (P≤0.005). In contrast, a significant increase in TGF-β expression was only observed in response to 10% and 20% PRP (P≤0.001) (Fig. 5A -B-C respectively). In addition, flow cytometry analyses showed a significant upregulation of the intracellular anti-inflammatory cytokines IL-10, IL-4 and IL-13 with all PRP concentrations (P≤0.005) (Fig. 6A -B-C respectively).
Regulation of Protease/protease inhibitor, collagen and aggrecan expression in OA chondrocytes by PRP
The inflammatory mediators in OA decrease the production of the cartilage matrix via a decrease of the expression of collagen and aggrecan. The expression of collagen and aggrecan is associated with a balance between protease and protease inhibitors. To determine whether PRP has an effect on the chondrocytes response in terms of protease/protease inhibitor release, chondrocytes were stimulated with PRP at varying concentrations and the effects on the expression at the mRNA and protein level were screened by q-PCR and ELISA respectively.
The relative expression of MMP3 decreased with different PRP concentrations but it was only significant with 20% PRP (P=0.005) at the mRNA level (Fig. 7-A) and with 10% and 20% at the protein level (P≤0.005) (Fig. 7-B) . Conversely, the mRNA and protein expressions of MMP13 and ADAMTS5 decreased significantly in a dose-dependent manner with all PRP concentrations (P≤0.001) (Fig. 7A-B respectively) .
Moreover, the protein expression of tissue inhibitor metalloproteinase TIMP1/3 was significantly increased with 10% and 20% PRP (P≤0.005). mRNA expression of TIMP1 was increased significantly by all PRP concentrations used (P≤0.005) contrary to TIMP2 mRNA expression which was not affected by PRP. TIMP3 mRNA expression increased significantly with 10% and 20% PRP (P≤0.005) (Fig. 7C-D) .
The regulation of MMPs and TIMPs was associated with a variation in the expression of extracellular matrix components collagen type 2 and aggrecan. The expression of these markers detected by q-PCR was higher in treated cells compared to control cells (P≤0.005) (Fig. 7E ).
Discussion
The amalgam between apoptosis, autophagy and the keys regulators of autophagy such as ADAMDTS-5, MMPs and collagen determine the degree of cartilage degradation and severity of osteoarthritis. Till today no medical treatment is capable considerably of reducing cartilage degradation, inflammation and progression of the disease. All present treatments are palliative. Recently, platelet rich plasma was reported to have anabolic effects on cartilage and is being used in clinical practice for the treatment of degenerative articular lesions in osteoarthritis, in tendinitis and other sports injuries [23] [24] [25] [26] [27] whereas we still have limited information on its mechanism of action. In our study, we found that platelet rich plasma increased the proliferation of chondrocytes, decreased apoptosis and increased autophagy in human osteoarthritic chondrocytes. Furthermore, PRP caused a dose-dependent decrease in MMP3, MMP13, and ADAMDTS-5, IL-6 and COX-2 while increased TGF-β, aggregan, collagen, TIMPs and intracellular anti-inflammatory cytokines IL-4, IL-10, and IL-13.
Autophagy is a mechanism of cell survival. It has been reported that it can protect against diverse diseases such as cancer [28] [29] [30] [31] , heart diseases [32] [33] [34] [35] , and aging [36, 37] . In tissues with little turnover such as articular cartilage, reversible quiescence is the normal stem-cell state throughout life. With aging cartilage, this quiescence will be lost due to intrinsic alterations [38, 39] . Senescence and autophagy are interrelated, and Garcia-Prat et al. showed that re-establishment of autophagy will reverse senescence and restores regenerative functions in aged cells [40] . Here we show that PRP induced a dose-dependent increase in chondrocytes quiescence thus reversing senescence of chondrocytes. Hence, we propose that the same mechanism described by Garcia-Prat et al. is taking place in OA cartilage, where autophagic cell death in aged OA chondrocytes [41] contributes to cartilage degradation and synovial inflammation. PRP is reversing this mechanism by revamping autophagy and, thus reversing senescence. In in situ articular cartilage, it could activate resident stem cells to renew this tissue. Our study is the first to demonstrate a role for PRP in restoring autophagy and promoting autophagosome formation. In addition, the transcription factors FOXO1 and FOXO3 were also significantly increased in a dosedependent manner when chondrocytes were cultured with PRP. We observed similar results with HIF-1 which is an accelerator of autophagy. A direct protein-protein interaction of HIF-1 and FOXO3 has been demonstrated in other studies where HIF-1 increases the FOXO3 protein synthesis, confirming the boosting effect of FOXO on autophagy [42] .
Dysregulation in the expression and activation of FOXO is involved in cartilage aging and osteoarthritis [8] . It has been reported that FOXO regulates the mechanisms of cellular aging including autophagy [43, 44] , and apoptosis [45] [46] [47] . The downregulation of FOXO increases the susceptibility to cell death [46] . In our study the increase in FOXO1 and FOXO3 and HIF-1 was accompanied by a decrease in apoptosis. The addition of increasing doses of PRP induced a significant decrease in the expression of caspase 3 and Bad while increasing significantly Bcl2 expression. The effect of PRP on apoptosis of osteoarthritic chondrocytes was not investigated directly before. Limited in vitro studies were performed on the role of PRP on chondrocytes apoptosis but they were combined with other molecules such as self-assembled peptide or stem cells [48, 49] and both studies described decreased apoptosis in the presence of PRP.
A strict interplay between apoptosis and inflammation is observed, such as when apoptosis increases, inflammatory mediators increase [50] . The inflammation of the synovial membrane occurring in both the early and late phases of OA is associated with alterations in the adjacent cartilage. The degradation of cartilage will perpetuate the inflammatory loop and lead to more degradation of cartilage and the non-stop of this vicious circle. The therapeutic aims in osteoarthritis are to interrupt this vicious circle, inhibit the inflammatory mediators, decrease the mediators of cartilage degradation and stimulate new cartilage formation. In our study PRP increased cell proliferation, decreased MMP-3, MMP-13 and ADAMDTS-5 expression at both the protein and mRNA levels while increasing TIMPS, collagen and aggregan. This suggests that PRP has a role in cartilage formation while inhibiting cartilage degradation. The decrease in MMPs, upregulation of TIMPs, collagen and aggregan by PRP was confirmed by various research groups while others mention either no effect, or a decrease in these parameters [51] [52] [53] [54] . The discrepancy in the results might be due to PRP preparations, the time of incubation and most importantly to the stage and severity of OA. We obtained our cartilage samples from severe osteoarthritic cases, mostly grade IV. Our results therefore indicate a potential therapeutic catabolic anti-inflammatory role for PRP on osteoarthritic cartilage; this role is consistent with our findings on the increase of anti-inflammatory mediators, IL-4, IL-10, IL-13 and TGF-β. To our knowledge there is no other report on the effect of PRP on anti-inflammatory cytokines in vitro. PRP increased significantly the intracellular expression of the three key cytokines known to play a major role in inhibiting inflammation and decreasing IL-1β mediated catabolic effect.
Current treatments for OA are palliative and focused on alleviating the symptoms but not stopping the progression or curing the disease. We think that PRP has a major role in modulating all the factors playing a role in the disease mechanism leading to cartilage degradation and perpetuating inflammations namely apoptosis, autophagy, MMPs, and ADAMDTs among others.
We suggest that PRP through the activation of the alpha granule and degranulation of its proteins such as PDGF, TGF-β, CTGF and FGF will bind to their respective receptors on collagen, osteoclast and chondrocytes to stimulate cartilage matrix synthesis and tissue regeneration hence inducing chondroprotection. It will also stimulate the resident cells to secrete other growth factors and anti-inflammatory cytokines to reduce inflammation and have similar protective effect on chondrocytes contributing to the reparative mechanism. We speculate that, in vivo, the effect will be much stronger and effective due to the presence of stem cells. PRP increase the proliferation and the secretion of anti-inflammatory cytokines and growth factors [55] such as TGF-β that will bind to these resident stem cells which will be activated and triggered to secrete their anti-inflammatory and other growth factors which will potentiate further the chondroprotective effect through their paracrine and trophic effect. Furthermore, the activation of the resident stem cells will push them to differentiate into new articular cartilage restoring the defect caused by the disease.
In conclusion, we think that PRP could be a potential therapeutic target for the treatment of osteoarthritis with or without the addition of stem cells depending on the age and the condition of the patient.
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